根據發(fa)行安排，4只科創板新(xin)股(gu)(gu)即(ji)將發(fa)行。12月(yue)28日(ri)發(fa)行的(de)是惠泰醫療(liao)；1月(yue)4日(ri)發(fa)行的(de)是浩歐(ou)博；1月(yue)5日(ri)發(fa)行的(de)是天能股(gu)(gu)份；1月(yue)6日(ri)發(fa)行的(de)是之(zhi)江(jiang)生物。即(ji)將發(fa)行的(de)這4只新(xin)股(gu)(gu)合計預計募資68.01億(yi)元。

　　惠(hui)泰醫(yi)療(liao)，發行日(ri)(ri)期(qi)為(wei)12月28日(ri)(ri)，申購(gou)代碼為(wei)787617，擬公開發行股(gu)票1667.00萬(wan)(wan)股(gu)，其中網上發行425.05萬(wan)(wan)股(gu)，發行價格為(wei)74.46元(yuan) ，發行市(shi)盈率(lv)為(wei)61.61倍(bei)，單一賬戶申購(gou)上限為(wei)0.40萬(wan)(wan)股(gu)，申購(gou)數量為(wei)500股(gu)的整數倍(bei)，頂格申購(gou)需持有滬市(shi)市(shi)值4.00萬(wan)(wan)元(yuan)。主營業(ye)務為(wei)電生理和血管(guan)介入醫(yi)療(liao)器械的研發、生產(chan)和銷售(shou)的高(gao)新(xin)技術(shu)企業(ye)。所屬行業(ye)為(wei)專用設(she)備制造業(ye)，2018年、2019年凈利潤分(fen)別為(wei)2151.20萬(wan)(wan)元(yuan)、8257.49萬(wan)(wan)元(yuan)，同比變動幅度為(wei)-37.61%、283.85%。

　　浩(hao)歐博，發行日期為(wei)1月4日，申(shen)購(gou)代(dai)碼為(wei)787656，擬公(gong)開(kai)發行股票1576.46萬(wan)股，預計募資6.09億(yi)元(yuan)(yuan)(yuan)，其中網上發行401.95萬(wan)股。主營業(ye)務為(wei)專業(ye)從事體外診斷試劑的研(yan)發、生(sheng)產和銷售(shou)。所屬行業(ye)為(wei)醫藥制造業(ye)，2018年、2019年凈利潤(run)分(fen)別為(wei)4015.44萬(wan)元(yuan)(yuan)(yuan)、6383.85萬(wan)元(yuan)(yuan)(yuan)，同比(bi)變動幅度(du)為(wei)88.04%、58.98%。

　　天能股(gu)(gu)份，發行日期為(wei)(wei)(wei)1月5日，申購代碼為(wei)(wei)(wei)787819，擬(ni)公開發行股(gu)(gu)票1.17億(yi)股(gu)(gu)，預計募資35.95億(yi)元，其中網(wang)上發行2070.00萬股(gu)(gu)。公司是一(yi)家(jia)以電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)輕型車動(dong)(dong)力(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)業務為(wei)(wei)(wei)主,集(ji)電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)特種車動(dong)(dong)力(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、新(xin)能源汽(qi)車動(dong)(dong)力(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、汽(qi)車起動(dong)(dong)啟停電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、儲能電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、3C電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、備用電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)等多品類(lei)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)的研發、生(sheng)產、銷售為(wei)(wei)(wei)一(yi)體的國內電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)行業領先企業之一(yi)。 所屬行業為(wei)(wei)(wei)電(dian)(dian)(dian)(dian)(dian)(dian)氣機械和(he)器材(cai)制造業，2018年(nian)、2019年(nian)凈利潤分別為(wei)(wei)(wei)12.17億(yi)元、14.92億(yi)元，同比變動(dong)(dong)幅度為(wei)(wei)(wei)8.43%、22.55%。

　　之江生(sheng)物，發行(xing)日期為1月6日，申購代碼為787317，擬公開發行(xing)股票4867.61萬(wan)(wan)股，預計募資13.56億元(yuan)，其中網上發行(xing)1241.20萬(wan)(wan)股。主營業務為分子診斷(duan)試劑(ji)及儀器設備的研發、生(sheng)產(chan)和銷售。所屬行(xing)業為醫藥制造(zao)業，2018年(nian)、2019年(nian)凈利潤(run)分別為6231.85萬(wan)(wan)元(yuan)、5152.18萬(wan)(wan)元(yuan)，同(tong)比變動幅度為20.93%、-17.33%。（數據(ju)寶）